These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10888331)

  • 41. Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells.
    Schmandt R; Liu SK; McGlade CJ
    Oncogene; 1999 Mar; 18(10):1867-79. PubMed ID: 10086341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain.
    Lung FD; Long YQ; Roller PP; King CR; Varady J; Wu XW; Wang S
    J Pept Res; 2001 Jun; 57(6):447-54. PubMed ID: 11437948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
    Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
    Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of phosphatidylinositol 3-kinase with SHC in chronic myelogeneous leukemia cells.
    Harrison-Findik D; Susa M; Varticovski L
    Oncogene; 1995 Apr; 10(7):1385-91. PubMed ID: 7537361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamin associates with Src-Homology Collagen (Shc) and becomes tyrosine phosphorylated in response to insulin.
    Baron V; Alengrin F; Van Obberghen E
    Endocrinology; 1998 Jun; 139(6):3034-7. PubMed ID: 9607818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 8-O-Methylsclerotiorinamine, antagonist of the Grb2-SH2 domain, isolated from Penicillium multicolor.
    Nam JY; Kim HK; Kwon JY; Han MY; Son KH; Lee UC; Choi JD; Kwon BM
    J Nat Prod; 2000 Sep; 63(9):1303-5. PubMed ID: 11000046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2 and Shc.
    Wellbrock C; Schartl M
    Eur J Biochem; 1999 Feb; 260(1):275-83. PubMed ID: 10091608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.
    Campbell KS; Ogris E; Burke B; Su W; Auger KR; Druker BJ; Schaffhausen BS; Roberts TM; Pallas DC
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6344-8. PubMed ID: 8022784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphatidylinositol 4,5-bisphosphate stimulates phosphorylation of the adaptor protein Shc by c-Src.
    Sato K; Yamamoto H; Otsuki T; Aoto M; Tokmakov AA; Hayashi F; Fukami Y
    FEBS Lett; 1997 Jun; 410(2-3):136-40. PubMed ID: 9237616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determining involvement of Shc proteins in signaling pathways.
    O'Bryan JP
    Methods Enzymol; 2001; 333():3-15. PubMed ID: 11400346
    [No Abstract]   [Full Text] [Related]  

  • 51. Global optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain.
    Long YQ; Lung FD; Roller PP
    Bioorg Med Chem; 2003 Sep; 11(18):3929-36. PubMed ID: 12927853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.
    Marengère LE; Waterhouse P; Duncan GS; Mittrücker HW; Feng GS; Mak TW
    Science; 1996 May; 272(5265):1170-3. PubMed ID: 8638161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.
    Curto M; Frankel P; Carrero A; Foster DA
    Biochem Biophys Res Commun; 1998 Feb; 243(2):555-60. PubMed ID: 9480847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
    Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
    J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
    Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
    Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
    Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC; Carvalho CR; Saad MJ
    Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.
    Pelicci G; Dente L; De Giuseppe A; Verducci-Galletti B; Giuli S; Mele S; Vetriani C; Giorgio M; Pandolfi PP; Cesareni G; Pelicci PG
    Oncogene; 1996 Aug; 13(3):633-41. PubMed ID: 8760305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of insulin-stimulated tyrosine phosphorylation of Shc and Shc/Grb2 association in liver, muscle, and adipose tissue of epinephrine- and streptozotocin-treated rats.
    Páez-Espinosa V; Rocha EM; Velloso LA; Saad MJ
    Endocrine; 2001 Apr; 14(3):295-302. PubMed ID: 11444425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monocarboxylic-based phosphotyrosyl mimetics in the design of GRB2 SH2 domain inhibitors.
    Burke TR; Luo J; Yao ZJ; Gao Y; Zhao H; Milne GW; Guo R; Voigt JH; King CR; Yang D
    Bioorg Med Chem Lett; 1999 Feb; 9(3):347-52. PubMed ID: 10091682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.